FIP Treatment Revolution: GS-441524 and Cat Welfare

The development of antiviral treatments for feline infectious peritonitis has transformed this previously fatal disease into a treatable condition.

Key Facts

FIP is caused by a mutated form of feline coronavirus that becomes systemically invasive
Until 2019, FIP was nearly universally fatal with no approved treatment
GS-441524 and mutian (nucleoside analogs) have cure rates of 85-90% in treated cats
Treatment requires daily injection or oral administration for 84 days minimum
Wet FIP (effusive) and dry FIP (non-effusive) both respond to antiviral treatment
Neurological and ocular FIP requires higher doses and longer treatment
In many countries these drugs remain unlicensed, requiring owners to source them through grey markets

Welfare Considerations

The FIP treatment revolution is one of the greatest recent advances in companion animal welfare. A disease that caused terrible suffering and inevitable death in young cats - fluid accumulation, wasting, neurological deterioration - is now curable in the majority of treated patients. Cats treated with GS-441524 recover to full, healthy lives. The welfare imperative now is ensuring access to effective treatment - cats in countries without licensed options face tragic outcomes that treated cats avoid. Advocacy for licensing and affordable access is a welfare priority.

What You Can Do

Suspect FIP in any young cat with unexplained fever, fluid accumulation, or neurological signs
Pursue diagnostic testing (protein analysis, coronavirus PCR, effusion analysis) promptly
Discuss GS-441524 or other antiviral treatment options with a vet experienced in FIP management
Complete the full treatment course - stopping early risks relapse
Connect with FIP support communities for guidance on sourcing treatment in countries without licensed options